Microsoft Cloud Authors: Elizabeth White, Yeshim Deniz, Serafima Al, Janakiram MSV, John Katrick

News Feed Item

World Pharma Contract Sales Industry and Market: Predictions 2014-2024

LONDON, February 13, 2014 /PRNewswire/ --

Outsourced selling of medicines - how to find trends, opportunities, and revenue prospects

What's the future of outsourcing pharma sales activities? Now you can get new forecasts for contracted promotional activities for prescription drugs. Stay ahead, then, for data. There you explore business results, developments, trends, opportunities, and predicted revenues.

Visiongain's new report shows you what's possible in those services for pharmaceuticals. Avoid missing out or losing authority. Instead you get financial analysis for that industry and market, discovering outlooks. Find progress in detailing and hear about the expected gains.

Read on to explore that contract healthcare sector, seeing what its future could be worth.

Knowledge to help your work and save time, benefiting your influence

Our study shows you trade predictions to 2024 at overall world, submarket, and national level. For those service offerings you investigate where money lies. Find what's possible.

Ever had trouble getting data you need? Yes, that's frustrating. Instead see how our report helps your research, analyses, and decisions for medical sales. Save time, too, and stay ahead. Also benefit your authority through better understanding the present and future.

Forecasts and other information showing opportunity in that pharmaceutical contracting

Besides forecasting revenues to 2024, that new work shows historical performance, recent results, growth rates, and market shares. There you get feel for companies' outlooks and potentials. You also gain 74 tables, 67 charts, and three interviews with that industry.

And the following sections explain in more detail what you get in the new investigation.

Forecasting of that world market and its main segments - what's likely to happen?

What's that industry's potential? What're the secrets of its progress? Discover in our report overall world revenue to 2024 for contract pharma sales operations.

Also see individual predictions of revenues to 2024 for ten submarkets at world level:

• Cardiovascular disease therapies
• Metabolic disorder treatments
• Cancer-treating agents
• Detailing
• Non-personal promotion.

And get forecasts for these fields and sub-analyses:

• Teledetailing
• Edetailing
• Medical education roles
• Sample management services
• Other related applications.

There you assess outlooks for business, hearing where you can gain. So investigate competition and rising sales. And discover lucrative possibilities there for syndicated pharma sales teams.

That work also shows you geographical predictions.

To see an exec summary of this report please email Sara Peerun on [email protected]

Healthcare in national markets - outlooks for contracted medical sales

Progress worldwide in healthcare expands use of contracted services for selling and promoting medicines to doctors and other drug prescribers.

You hear about the best revenue prospects for those outsourced and off-shored operations, appraising national opportunities. See where and how you could profit.

Our analyses show you individual revenue forecasts to 2024 for 11 national markets:

United States (US)
Germany, France, UK, Italy, and Spain (EU5), also with EU regional prediction
Brazil, Russia, India, and China (BRIC nations).

There you find countries with highest revenues, demands, and potential sales growth. Stay ahead, then, for information. You find international prospects for promoting and selling to medical practitioners.

And what events change that market? Our work shows you, discussing trends and needs.

Developments, challenges, and effects influencing contract sales organisations (CSOs)

The report also explains issues, forces, and events affecting the CSO industry and market from 2014:

• Numbers of contract and in-house sales reps - trends and emerging sales models
• Services CSOs offer and benefits to drug companies outsourcing pharma sales
• Maturing brands and product launches, inc. flexibility in field sales teams
• Physician payment legislation in the US, Europe, and Japan, and new market access requirements for pharma sales representatives - regulatory outlooks
• Changes to online marketing rules for prescription drugs
• Multichannel marketing, key account management (KAM), key opinion leaders (KOLs), and medical science liaison (MSL).

And you explore these influences, among others:

• Smartphones and tablets for new detailing strategies - advances in technology
• Closed loop marketing (CLM), cloud computing, and customer relationship management (CRM), inc. social media use and big data
• Cuts to in-house sales staff - implications for outsourcing service providers
• Strategic partnering and CSO consolidation - networks, links and alliances
• Needs for biological drugs (biologics), biosimilars, and other specialty medicines (with overall world revenue predictions to 2024 for biologics and biosimilars).

There you find what stimulates and restrains players in that industry, and affects its results.

Analysis of companies and potential for market growth - what's possible from 2014?

Our study predicts the world market for pharma contract selling will reach $5.9bn in 2018.

There large pharma service contractors and specialists can profit, expanding business from 2014 to 2024. The new analysis shows you gains possible.

So what happens next? In particular, our report assesses these companies' activities:

• Quintiles
• inVentiv Health
• UDG Healthcare
• Publicis Touchpoint Solutions
• OnCall.

There you analyse participants' results, capabilities, and outlooks. You also read three interviews with firms in the industry. Discover what pharma outsourcing providers do, say, and think, helping you stay ahead.

To see an exec summary of this report please email Sara Peerun on [email protected]

Ways World Pharma Contract Sales Industry and Market: Predictions 2014-2024  helps

Through knowledge such as this, our new report helps you get recognition for insight:

• Revenues there to 2024 at world level, with forecasts for 10 submarkets - assess prospects for investments, marketing, and revenues
• Forecasts to 2024 for 11 national markets in the Americas, Europe, and Asia - investigate developed and developing countries for commercial potentials
• Outlooks for established, rising, and emerging service providers - explore results, capabilities, news, technologies, portfolios, and strategies.

Knowledge found nowhere else, helping your searches, analyses, and plans

Our study gives independent analysis. There you receive competitive intelligence found only in our work, finding where progress and money lie. You explore the commercial possibilities.

So with our data you're less likely to fall behind in knowledge or miss opportunity. Being free to choose, you find with our study how you could save time and effort. Also help your planning, decisions, competing, and authority.

Predictions for outsourced pharma selling - gain by trying our report now

This new report is for everyone investigating medical promotions and selling. There you find revenue forecasting to 2024, with discussions. Avoid missing out - please order it now.

To request an exec summary of this report please email Sara Peerun at [email protected] 

Or click on http://www.visiongain.com/Report/1199/World-Pharma-Contract-Sales-Industry-and-Market-Predictions-2014-2024

Companies Listed in this report:

Addison Whitney (part of inVentiv Health)
Adheris (part of inVentiv Health)
Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM) [France]
Agência Nacional de Vigilância Sanitária (ANVISA) [Brazil]
Agenzia Italiana del Farmaco (AIFA)
Alliance Healthcare (part of UDG Healthcare)
American Medical Association (AMA)
Arena Pharmaceuticals
Ashfield Healthcare (part of UDG Healthcare)
Ashfield Healthcare Ireland (part of UDG Healthcare)
Ashfield Healthcare USA (part of UDG Healthcare)
Ashfield In2Focus (part of UDG Healthcare)
Ashfield KK (part of UDG Healthcare)
Association of the British Pharmaceutical Industry (ABPI)
Bain Capital
Boehringer Ingelheim
Business Edge Solutions and Training (BEST, part of UDG Healthcare)
Catalina Health (part of Adheris)
Centers of Medicare and Medicaid Services (CMS) [US]
Chandler Chicco (part of inVentiv Health)
CMR Institute
Dayarn Pharma
Drug Safety Alliance (DSA, part of UDG Healthcare)
Eli Lilly
Endo Pharmaceuticals
European Commission (EC)
European Federation of Pharmaceutical Industries and Associations (EFPIA)
European Promotional Product Association (EPPA)
Evolve Selection
Expansis (part of UDG Healthcare)
Express Scripts
Gesamtverband der Werbeartikel Wirtschaft e.V. (GWW) [Germany]
Go! Healthcare Marketing
Grey Healthcare Group
Group DCA (part of PDI)
GSW Worldwide (part of inVentiv Health)
Health Kare Pharma International
IMS Health
Innovex (part of Quintiles)
InsightOut (part of inVentiv Health)
Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesenis (IQWiG) [Germany]
International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
Interpace BioPharma (part of PDI)
Interpace Diagnostics (part of PDI)
inVentiv Creative Studios (part of inVentiv Health)
inVentiv Digital+Innovation (part of inVentiv Health)
inVentiv Health
inVentiv Health Korea (part of inVentiv Health)
inVentiv Japan (part of inVentiv Health)
inVentiv Media 360º (part of inVentiv Health)
inVentiv Medical Communications (part of inVentiv Health)
inVentiv Medical Management (part of inVentiv Health)
inVentiv Patient Access Solutions (part of inVentiv Health)
inVentiv Recruitment Services (part of inVentiv Health)
inVentiv Selling Solutions (part of inVentiv Health)
inVentiv Therapeutics Institute (part of inVentiv Health)
J. Knipper & Co.
Japan Contract Sales Organization Association (JCSOA)
Japan Pharmaceutical Manufacturers Association (JPMA)
JSA (part of inVentiv Health)
Les enterprises du médicament (LEEM) [France]
Lupin Pharmaceuticals
MDS Co. (part of CMIC)
Medical Communications Group (MCG, part of UDG Healthcare)
Medical Council of India (MCI)
Menarini Asia-Pacific (formerly Invida)
Menarini Group
Merck & Co.
Merqurio Pharma
Ministère des Affaires sociales et de la Santé [France]
Ministério da Saúde [Brazil]
Ministry of Health [China]
MKM Group
National Health Service (NHS) [UK]
National Institute for Health and Care Excellence (NICE) [UK]
Neurocrine Biosciences
Norwegian Medicines Agency (NoMA)
NovaMed Pharmaceuticals
Novo Nordisk
Organization of Pharmaceutical Producers of India (OPPI)
Otsuka Pharmaceutical
Palio+Ignite (part of inVentiv Health)
ParagonRx (part of inVentiv Health)
Patient Marketing Group (part of inVentiv Health)
PDI Voice (part of PDI)
Pharmaceutical Research and Manufacturers of America (PhRMA)
Pharmagistics (part of J. Knipper)
Pharmexx (part of UDG Healthcare)
Promius Pharma
Publicis Groupe
Publicis Health Communications Group
Publicis Touchpoint Solutions
Q.E.D International (part of Quintiles)
Ramco Import Export
Sandoz (part of Novartis)
Scientific Voice (part of Publicis Touchpoint Solutions)
Sinclair IS Pharma
Sofip (Société de Franchise pour l'Information Pharmaceutique)
Synopia Rx (part of UDG Healthcare)
Temas (part of Quintiles)
Temasek Holdings
Teva Pharmaceutical Industries
The Navicor Group (part of inVentiv Health)
Thomas H. Lee Partners
UDG Healthcare
Universal WorldEvents (part of UDG Healthcare)
US Congressional Budget Office (CBO)
US Food and Drug Administration (FDA)
VCG & Associates (part of Quintiles)
Veeva Systems
Warner Chilcott (part of Actavis)
World Health Organization (WHO)
Zuellig Group
Zuellig Pharma (part of Zuellig Group)

To see an exec summary of this report please email Sara Peerun on [email protected] or call Tel: +44-(0)20-7336-6100

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

@ThingsExpo Stories
Cloud-enabled transformation has evolved from cost saving measure to business innovation strategy -- one that combines the cloud with cognitive capabilities to drive market disruption. Learn how you can achieve the insight and agility you need to gain a competitive advantage. Industry-acclaimed CTO and cloud expert, Shankar Kalyana presents. Only the most exceptional IBMers are appointed with the rare distinction of IBM Fellow, the highest technical honor in the company. Shankar has also receive...
Enterprises have taken advantage of IoT to achieve important revenue and cost advantages. What is less apparent is how incumbent enterprises operating at scale have, following success with IoT, built analytic, operations management and software development capabilities - ranging from autonomous vehicles to manageable robotics installations. They have embraced these capabilities as if they were Silicon Valley startups.
Poor data quality and analytics drive down business value. In fact, Gartner estimated that the average financial impact of poor data quality on organizations is $9.7 million per year. But bad data is much more than a cost center. By eroding trust in information, analytics and the business decisions based on these, it is a serious impediment to digital transformation.
Predicting the future has never been more challenging - not because of the lack of data but because of the flood of ungoverned and risk laden information. Microsoft states that 2.5 exabytes of data are created every day. Expectations and reliance on data are being pushed to the limits, as demands around hybrid options continue to grow.
The standardization of container runtimes and images has sparked the creation of an almost overwhelming number of new open source projects that build on and otherwise work with these specifications. Of course, there's Kubernetes, which orchestrates and manages collections of containers. It was one of the first and best-known examples of projects that make containers truly useful for production use. However, more recently, the container ecosystem has truly exploded. A service mesh like Istio addr...
Digital Transformation: Preparing Cloud & IoT Security for the Age of Artificial Intelligence. As automation and artificial intelligence (AI) power solution development and delivery, many businesses need to build backend cloud capabilities. Well-poised organizations, marketing smart devices with AI and BlockChain capabilities prepare to refine compliance and regulatory capabilities in 2018. Volumes of health, financial, technical and privacy data, along with tightening compliance requirements by...
As IoT continues to increase momentum, so does the associated risk. Secure Device Lifecycle Management (DLM) is ranked as one of the most important technology areas of IoT. Driving this trend is the realization that secure support for IoT devices provides companies the ability to deliver high-quality, reliable, secure offerings faster, create new revenue streams, and reduce support costs, all while building a competitive advantage in their markets. In this session, we will use customer use cases...
Business professionals no longer wonder if they'll migrate to the cloud; it's now a matter of when. The cloud environment has proved to be a major force in transitioning to an agile business model that enables quick decisions and fast implementation that solidify customer relationships. And when the cloud is combined with the power of cognitive computing, it drives innovation and transformation that achieves astounding competitive advantage.
DevOpsSummit New York 2018, colocated with CloudEXPO | DXWorldEXPO New York 2018 will be held November 11-13, 2018, in New York City. Digital Transformation (DX) is a major focus with the introduction of DXWorldEXPO within the program. Successful transformation requires a laser focus on being data-driven and on using all the tools available that enable transformation if they plan to survive over the long term. A total of 88% of Fortune 500 companies from a generation ago are now out of bus...
With 10 simultaneous tracks, keynotes, general sessions and targeted breakout classes, @CloudEXPO and DXWorldEXPO are two of the most important technology events of the year. Since its launch over eight years ago, @CloudEXPO and DXWorldEXPO have presented a rock star faculty as well as showcased hundreds of sponsors and exhibitors! In this blog post, we provide 7 tips on how, as part of our world-class faculty, you can deliver one of the most popular sessions at our events. But before reading...
DXWordEXPO New York 2018, colocated with CloudEXPO New York 2018 will be held November 11-13, 2018, in New York City and will bring together Cloud Computing, FinTech and Blockchain, Digital Transformation, Big Data, Internet of Things, DevOps, AI, Machine Learning and WebRTC to one location.
DXWorldEXPO LLC announced today that ICOHOLDER named "Media Sponsor" of Miami Blockchain Event by FinTechEXPO. ICOHOLDER give you detailed information and help the community to invest in the trusty projects. Miami Blockchain Event by FinTechEXPO has opened its Call for Papers. The two-day event will present 20 top Blockchain experts. All speaking inquiries which covers the following information can be submitted by email to [email protected] Miami Blockchain Event by FinTechEXPO also offers s...
DXWorldEXPO | CloudEXPO are the world's most influential, independent events where Cloud Computing was coined and where technology buyers and vendors meet to experience and discuss the big picture of Digital Transformation and all of the strategies, tactics, and tools they need to realize their goals. Sponsors of DXWorldEXPO | CloudEXPO benefit from unmatched branding, profile building and lead generation opportunities.
Dion Hinchcliffe is an internationally recognized digital expert, bestselling book author, frequent keynote speaker, analyst, futurist, and transformation expert based in Washington, DC. He is currently Chief Strategy Officer at the industry-leading digital strategy and online community solutions firm, 7Summits.
Digital Transformation and Disruption, Amazon Style - What You Can Learn. Chris Kocher is a co-founder of Grey Heron, a management and strategic marketing consulting firm. He has 25+ years in both strategic and hands-on operating experience helping executives and investors build revenues and shareholder value. He has consulted with over 130 companies on innovating with new business models, product strategies and monetization. Chris has held management positions at HP and Symantec in addition to ...
The best way to leverage your Cloud Expo presence as a sponsor and exhibitor is to plan your news announcements around our events. The press covering Cloud Expo and @ThingsExpo will have access to these releases and will amplify your news announcements. More than two dozen Cloud companies either set deals at our shows or have announced their mergers and acquisitions at Cloud Expo. Product announcements during our show provide your company with the most reach through our targeted audiences.
The IoT Will Grow: In what might be the most obvious prediction of the decade, the IoT will continue to expand next year, with more and more devices coming online every single day. What isn’t so obvious about this prediction: where that growth will occur. The retail, healthcare, and industrial/supply chain industries will likely see the greatest growth. Forrester Research has predicted the IoT will become “the backbone” of customer value as it continues to grow. It is no surprise that retail is ...
Andrew Keys is Co-Founder of ConsenSys Enterprise. He comes to ConsenSys Enterprise with capital markets, technology and entrepreneurial experience. Previously, he worked for UBS investment bank in equities analysis. Later, he was responsible for the creation and distribution of life settlement products to hedge funds and investment banks. After, he co-founded a revenue cycle management company where he learned about Bitcoin and eventually Ethereal. Andrew's role at ConsenSys Enterprise is a mul...
DXWorldEXPO LLC announced today that "Miami Blockchain Event by FinTechEXPO" has announced that its Call for Papers is now open. The two-day event will present 20 top Blockchain experts. All speaking inquiries which covers the following information can be submitted by email to [email protected] Financial enterprises in New York City, London, Singapore, and other world financial capitals are embracing a new generation of smart, automated FinTech that eliminates many cumbersome, slow, and expe...
Cloud Expo | DXWorld Expo have announced the conference tracks for Cloud Expo 2018. Cloud Expo will be held June 5-7, 2018, at the Javits Center in New York City, and November 6-8, 2018, at the Santa Clara Convention Center, Santa Clara, CA. Digital Transformation (DX) is a major focus with the introduction of DX Expo within the program. Successful transformation requires a laser focus on being data-driven and on using all the tools available that enable transformation if they plan to survive ov...